Pneumonia Drug for COVID19 Treatment

Pneumonia Drug for COVID19 Treatment

BioAegis

Category

Laboratory

Country

United States of America (USA), North America

Description

BioAegis Therapeutics is using its lead product for severe pneumonia, rhu-pGSN as an otion for treatment for COVID19.